+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06399926

Study of Intraventricular Pemetrexed Disodium via Ommaya Reservoir for Safety and Effectiveness in Treating Leptomeningeal Metastasis from Lung Cancer After Targeted Therapy Failure

Led by Xiangya Hospital of Central South University · Updated on 2024-05-06

64

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

This research is an open-label, multi-center prospective observational study evaluating the safety and effectiveness of intraventricular pemetrexed disodium administered via an Ommaya reservoir. It focuses on patients with leptomeningeal metastasis from lung cancer who have not responded to at least one targeted therapy, including those who failed third-generation EGFR-TKIs for EGFR-mutated lung cancer, second-generation ALK-TKIs for ALK-mutated lung cancer, or one line of targeted TKIs for ROS1-mutated non-squamous non-small cell lung cancer. Participants are assigned to one of two groups. Cohort 1 receives pemetrexed 20mg every 24 hours for 72 hours every 2 weeks during induction, switching to every 3 weeks during consolidation if remission or stable disease is observed. Cohort 2 receives pemetrexed 30mg once weekly during induction, then every 3 weeks in consolidation. Treatment continues until intolerance or disease progression. A crossover may occur between cohorts based on early comparative evaluation of efficacy and toxicity. Throughout the study, participants undergo regular efficacy assessments every two cycles, including cerebrospinal fluid cytology tests. Monitoring includes evaluation of response rates at 3 months and long-term outcomes like disease control, progression-free survival, overall survival, cytology clearance, and adverse effects over two years. Participants must adhere to scheduled visits, treatments, and laboratory tests as outlined in the protocol during the entire study period.

CONDITIONS

Brief Title

Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir

Research Team

B

bin Li, doctor

X

xiangping Li, pharmacist

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here